Skip to main content

Table 2 Cox regression analyses of the associations of miR-130a and clinical characteristics with OS in TCGA

From: miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase

Variable Univariate Cox regression Multivariate Cox regression
  Hazard ratio 95% CI p value Hazard ratio 95% CI p value
Gender 0.776 0.536–1.125 0.181    
Age 1.027 1.012–1.042 0.001 1.016 0.998–1.035 0.088
MGMT methylation 0.559 0.361–0.864 0.009 0.654 0.413–1.008 0.054
miR-130a 0.558 0.426–0.733 0.000 0.665 0.473–0.935 0.019
  1. CI, confidence interval; MGMT, O-6-methylguanine-DNA methyltransferase.